Inventor · disambiguated record
Erik Daa Funder
Also filed as: FUNDER ERIK · FUNDER ERIK DAA
9 granted patents·12 pending applications·4 citations·filing 2017–2025
77Inventor score
Top patents by PatentIndex Score
21 records- 0181US11267843B2Stereodefining L-monomersROCHE INNOVATION CT COPENHAGEN AS·Filed 2017·Granted Mar 8, 2022·2 cites·4 claims
- 0274US11542501B2Antisense oligonucleotides targeting ATXN3HOFFMANN LA ROCHE·Filed 2020·Granted Jan 3, 2023·1 cites·15 claims
- 0372US11261209B2Enhanced coupling of stereodefined oxazaphospholidine phosphoramidite monomers to nucleoside or oligonucleotideROCHE INNOVATION CT COPENHAGEN AS·Filed 2017·Granted Mar 1, 2022·1 cites·12 claims
- 0470US2024182898A1ENHANCED OLIGONUCLEOTIDES FOR INHIBITING RTELl EXPRESSIONHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0568US11898145B2Enhanced oligonucleotides for inhibiting RTEL1 expressionHOFFMANN LA ROCHE·Filed 2022·Granted Feb 13, 2024·0 cites·17 claims
- 0668US2024368593A1Gapmer oligonucleotides comprising a phosphorodithioate internucleoside linkageROCHE INNOVATION CT COPENHAGEN AS·Filed 2024·Application pending·0 cites
- 0767US2025034576A1Double Stranded Oligonucleotide For Modulating JAK1 ExpressionHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 0865US2024409939A1Combination of oligonucleotides for modulating rtel1 and fubp1HOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 0962US2023002762A1Oligonucleotides comprising a phosphorodithioate internucleoside linkageROCHE INNOVATION CT COPENHAGEN AS·Filed 2022·Application pending·0 cites
- 1055US2023060373A1Antisense Oligonucleotides Targeting ATXN3HOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 1154US2020318103A1Stereodefined sub-motif optimisation methodsROCHE INNOVATION CT COPENHAGEN AS·Filed 2020·Application pending·0 cites
- 1253US11667660B2Pyridinium salts as activators in the synthesis of stereodefined oligonucleotidesROCHE INNOVATION CT COPENHAGEN AS·Filed 2021·Granted Jun 6, 2023·0 cites·17 claims
- 1353US2020339982A1Oligonucleotides comprising a phosphorodithioate internucleoside linkageROCHE INNOVATION CT COPENHAGEN AS·Filed 2018·Application pending·0 cites
- 1453US2022177883A1Antisense Oligonucleotides Targeting ATXN3HOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 1550US12344625B2Process for preparing rhenium chelated MAG3 oligonucleotidesROCHE INNOVATION CT COPENHAGEN AS·Filed 2020·Granted Jul 1, 2025·0 cites·17 claims
- 1650US2020332289A1Gapmer oligonucleotides comprising a phosphorodithioate internucleoside linkageROCHE INNOVATION CT COPENHAGEN AS·Filed 2018·Application pending·0 cites
- 1750US2025250571A1Double-stranded rna molecule for administration to the eyeHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 1850US2023054720A1Antisense Oligonucleotides Targeting ATXN3HOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 1948US12421268B2Process for preparing nucleotide P(V) monomersROCHE INNOVATION CT COPENHAGEN AS·Filed 2020·Granted Sep 23, 2025·0 cites·14 claims
- 2048US11591362B2Orthogonal protecting groups for the preparation of stereodefined phosphorothioate oligonucleotidesROCHE INNOVATION CT COPENHAGEN AS·Filed 2018·Granted Feb 28, 2023·0 cites·39 claims
- 2144US11814407B2Multiple coupling and oxidation methodROCHE INNOVATION CT COPENHAGEN AS·Filed 2018·Granted Nov 14, 2023·0 cites·9 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →